218 related articles for article (PubMed ID: 9007525)
1. Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model.
Langlois A; Pascaud X; Junien JL; Dahl SG; Rivière PJ
Eur J Pharmacol; 1996 Dec; 318(1):141-4. PubMed ID: 9007525
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
3. Constipation evoked by 5-HT3-receptor antagonism: evidence for heterogeneous efficacy among different antagonists in guinea-pigs.
Sanger GJ; Wardle KA
J Pharm Pharmacol; 1994 Aug; 46(8):666-70. PubMed ID: 7815281
[TBL] [Abstract][Full Text] [Related]
4. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD
Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418
[TBL] [Abstract][Full Text] [Related]
5. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
Miyata K; Kamato T; Yamano M; Nishida A; Ito H; Katsuyama Y; Yuki H; Tsutsumi R; Ohta M; Takeda M
J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629
[TBL] [Abstract][Full Text] [Related]
6. The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension.
Moss HE; Sanger GJ
Br J Pharmacol; 1990 Jul; 100(3):497-501. PubMed ID: 2167734
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-hydroxytryptamine 3 receptor antagonists on gastrointestinal motor activity in conscious dogs.
Yoshida N; Mizumoto A; Iwanaga Y; Itoh Z
J Pharmacol Exp Ther; 1991 Jan; 256(1):272-8. PubMed ID: 1846418
[TBL] [Abstract][Full Text] [Related]
8. Differences between 5-HT3 receptor antagonists in modulation of visceral hypersensitivity.
Banner SE; Sanger GJ
Br J Pharmacol; 1995 Jan; 114(2):558-62. PubMed ID: 7881756
[TBL] [Abstract][Full Text] [Related]
9. The activity of dihydropyrimidine dehydrogenase from rat liver was not affected by any of five 5-hydroxytryptamine antagonists.
Tateishi T; Nakura H; Watanabe M; Tanaka M; Kumai T; Kobayashi S
Cancer Lett; 1996 Nov; 108(1):1-5. PubMed ID: 8950202
[TBL] [Abstract][Full Text] [Related]
10. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
[TBL] [Abstract][Full Text] [Related]
11. 5-HT4 receptor antagonism potentiates inhibition of intestinal allodynia by 5-HT3 receptor antagonism in conscious rats.
Smith MI; Banner SE; Sanger GJ
Neurosci Lett; 1999 Aug; 271(1):61-4. PubMed ID: 10471214
[TBL] [Abstract][Full Text] [Related]
12. 5-HT3 receptor-independent inhibition of the depolarization-induced 86Rb efflux from human neuroblastoma cells, TE671, by ondansetron.
Toral J; Hu W; Critchett D; Solomon AJ; Barrett JE; Sokol PT; Ziai MR
J Pharm Pharmacol; 1995 Jul; 47(7):618-22. PubMed ID: 8568632
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
Eglen RM; Swank SR; Walsh LK; Whiting RL
Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
[TBL] [Abstract][Full Text] [Related]
14. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
Bhandari P; Andrews PL
Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456
[TBL] [Abstract][Full Text] [Related]
15. Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats.
Bardin L; Jourdan D; Alloui A; Lavarenne J; Eschalier A
Brain Res; 1997 Aug; 765(2):267-72. PubMed ID: 9313899
[TBL] [Abstract][Full Text] [Related]
16. Stimulant effects of 5-hydroxytryptamine on guinea pig stomach preparations in vitro.
Buchheit KH; Buhl T
Eur J Pharmacol; 1994 Sep; 262(1-2):91-7. PubMed ID: 7813582
[TBL] [Abstract][Full Text] [Related]
17. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
Gullikson GW; Loeffler RF; Viriña MA
J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
[TBL] [Abstract][Full Text] [Related]
18. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
[TBL] [Abstract][Full Text] [Related]
19. Anorectic response to amino acid imbalance: a selective serotonin3 effect?
Jiang JC; Gietzen DW
Pharmacol Biochem Behav; 1994 Jan; 47(1):59-63. PubMed ID: 8115429
[TBL] [Abstract][Full Text] [Related]
20. BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors.
Newberry NR; Watkins CJ; Sprosen TS; Blackburn TP; Grahame-Smith DG; Leslie RA
Neuropharmacology; 1993 Aug; 32(8):729-35. PubMed ID: 8413836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
